Abstract
Tuberculosis (TB) control in nomadic populations represents a major public health problem in sub–Saharan Africa.
Barriers and enablers of TB care for nomads were identified through a literature review and survey conducted among the National TB Programs (NTPs) of six Sahelian countries: Burkina Faso, Chad, Niger, Mali, Mauritania, and Senegal. A conceptual framework was developed. Data retrieved from twenty-eight peer-reviewed papers or collected through the survey were regrouped in 5 categories: health system related factors, socioeconomic factors, cultural, political and environmental factors.
The large distance between nomadic camps and health care facilities and the absence of TB-specific programmatic interventions for nomads were the main barriers identified. The establishment of a multi-ministerial national committee in charge of nomadic populations, the mapping of nomadic transhumance roads, the identification of gaps in health service provision and community engagement for defining fit for purpose solutions are key elements to improve TB control in nomadic population.
Some countries in the region successfully implemented interventions to overcome the barriers to TB care. These interventions should be more widely shared to inform other countries for the development of appropriate strategies for which community engagement is essential.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Data collection at country level through questionnaire, data review, data analysis were not funded. None of the authors were paid to write this scientific paper and publish it. The special programme of the World Health Organisation for Research Training in Tropical Disease (WHO/TDR) is funding the submission of the paper as part of its support to WARN-TB and CARN-TB Networks (« West African Regional Networks for TB control » and « Central African Régional Networks for TB control»
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Not Applicable
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Not applicable
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Not Applicable
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Not Applicable
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Not Applicable
Footnotes
RC and CSM designed the study
AC, AD, SO, MO, AS, MS, NT, KB, OA, AA, BK, YB, FC, EK, MK, RC and HT, collected data
HT, RC and CSM planned the analyses and interpreted data MR provided advices for data analyses.
HT, CSM, MR wrote the paper.
All authors reviewed and approved the final version of the manuscript, decided to publish the manuscript, and agreed to be accountable for all aspects of the work
Data Availability
All data related the findings are already provided of the submitted article.